Biogen expects $164M R&D charge to hit Q2 2026 earnings

Go back to Biogen expects $164M R&D charge to hit Q2 2026 earnings
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 197.74 --0 (-0%)
Previous Close $197.74    52 Week High $333.65 
Open $197.74    52 Week Low $223.02 
Day High $197.74    P/E 25.32 
Day Low $197.74    EPS $7.81 
Volume